Method development of di-(2-ethylhexyl) phthalate metabolites detection by dispersive liquid–liquid microextraction gas chromatography–mass spectrometry from urine
Mohammad Mehdi Amin1, Karim Ebrahimpour1, Saeed Parastar2, Bahareh Shoshtari-Yeganeh1, Majid Hashemi2
1 Environment Research Center, Research Institute for Primordial Prevention of Noncommunicable Disease; Department of Environmental Health Engineering, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Environmental Health Engineering, School of Health; Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran
|Date of Submission||16-Dec-2017|
|Date of Acceptance||07-Feb-2018|
|Date of Web Publication||23-May-2018|
Department of Environmental Health Engineering, School of Health, Isfahan University of Medical Sciences, Isfahan
Source of Support: None, Conflict of Interest: None
Aims: Phthalates (e.g., diethylhexyl phthalate) act as one of the endocrine disruptive compounds and can have adverse effects on different biological pathways including hormonal receptors, affecting the synthesis, secretion, or metabolism of hormones. The aim of this study was, method development of the dispersive liquid-liquid microextraction (DLLME), to determine the monoesters of diethylhexyl phthalate in children and adolescents in Isfahan city, Iran. Materials and Methods: This study was conducted in 2016 (during a year) on 242 children and adolescents, aged 6–18 years, living in Isfahan, Iran. In this method, acetonitrile and chlorobenzene were used as disperser and extractant, respectively, to extract the investigated monoesters. The analytes were determined by gas chromatography–mass spectrometry. Results: Acetonitrile (as disperser) and chlorobenzene (as extractant) were used for monoester phthalates extraction (750 μl of acetonitrile and 80 μl of chlorobenzene). The results indicated that the recovery and relative standard deviation (RSD) of the utilized method were 55–109 and 6.3%–13.2%, respectively. The limit of detection and limit of quantification (LOQ) of the method were 0.024–0.088 and 0.05–0.48 μg/L, respectively. Monoethylhexyl phthalate (MEHP), monoethyl oxo-hexyl-phthalate (MEOHP), and monoethyl hydroxyl-hexyl-phthalate (MEHHP) were observed in 99.6%, 95.87%, and 96.28% of the studied samples, respectively. The mean concentration of MEHP, MEOHP, and MEHHP in the study population was 151.7 ± 143.8, 258.26 ± 143.07, and 194.17 ± 147.3 μg/L, respectively. Conclusion: Acetonitrile (as disperser) and chlorobenzene (as extractant) were suitable solvents for phthalate monoesters extraction in method development of DLLME. On the other hand, the mean concentrations were very high values in comparison with other similar studies that require the attention and legislation regarding limitation of the application of phthalate compounds.
Keywords: Biomonitoring, Isfahan, metabolite, urinary phthalates
|How to cite this article:|
Amin MM, Ebrahimpour K, Parastar S, Shoshtari-Yeganeh B, Hashemi M. Method development of di-(2-ethylhexyl) phthalate metabolites detection by dispersive liquid–liquid microextraction gas chromatography–mass spectrometry from urine. Int J Env Health Eng 2018;7:4
|How to cite this URL:|
Amin MM, Ebrahimpour K, Parastar S, Shoshtari-Yeganeh B, Hashemi M. Method development of di-(2-ethylhexyl) phthalate metabolites detection by dispersive liquid–liquid microextraction gas chromatography–mass spectrometry from urine. Int J Env Health Eng [serial online] 2018 [cited 2019 Feb 15];7:4. Available from: http://www.ijehe.org/text.asp?2018/7/1/4/233097
| Introduction|| |
Phthalates are industrial chemicals used as a plasticizer to develop resilience and stability in plastic products,,,,, personal care products (i.e., cosmetics, perfume, and lotions), colors, and glaze. Low molecular weight phthalates (e.g., diethyl phthalate, di-n-butyl phthalate, di-n-octyl phthalate, and di-n-isobutyl phthalate) are mostly used in shampoos, cosmetics, lotions, and other personal care products to preserve perfume and scent. On the other hand, high molecular weight phthalate (e.g., di-2-ethylhexyl phthalate and butyl benzyl phthalate [BBzP]) are utilized for production of plastic to be used in floor covering and light packaging of foods.,, Over the past decade, concerns over the health risks associated with exposure to the phthalate compounds, especially sensitive population such as pregnant mothers and children, have increased. Phthalate acts as an endocrine glands' disruptor and can affect hormonal receptors, synthesis, secretion, or metabolism of hormones through biological pathways., Exposure to phthalate alters the hormonal level and brings about adverse effects to men fertility, precocious puberty in girls (exposure to phthalates causes girls to reach puberty earlier and have a shorter stature), increased incidence of chronic diseases, and possible role in the development of cancer.
Due to the toxic properties of phthalates, the European Commission has inhibited the use of phthalate compounds such as di-2-ethyl hexyl phthalate (DEHP), dibutyl phthalate (DBP), and BBzP in the production of toys and goods associated with children. Phthalates such as DEHP, DBP, and BBzP should not be used in cosmetics and consumer products such as colors and resins. Moreover, their usage in materials that are in contact with food products is not allowable either. Usage of DEHP in medical polyvinyl chloride devices is limited for cases when it causes exposure of newborn infants. Metabolism of phthalates develops monoester phthalate compounds, which can be metabolized into oxidative compounds. Phthalates are rapidly metabolized in the body through hydrolysis mechanism (over 24–48 h after exposure) and are converted to monoester metabolites. They are then re-metabolized or removed from the body in urine in the form of glucuronides. [Figure 1] represents the metabolism pathway of DEHP decomposition in the human body.
Biomonitoring is used for evaluation of human exposure to chemicals. Hines et al. investigated the concentration of metabolites in different matrices (blood, urine, milk, saliva, and serum). To use biomonitoring in the evaluation of human exposure to nonresistant chemicals, urine is usually a suitable choice, as the levels of metabolites are higher in urine than in blood, and its collection is also easier. Various studies have been conducted regarding biomonitoring of urinary metabolites of phthalate including biomonitoring of phthalate compounds across pregnant women in Rotterdam City in the Netherlands, Danish mothers and children, Canadian people (6–49 years), 8–13 year-old Mexican children, and 3–14 year-old German children. The most extensive biomonitoring study has been conducted by Centers for Disease Control and Prevention (CDC) in the US in the form of a plan called National Health and Nutrition Examination Survey (NHANES). This plan has taken a representative statistical sample out of the entire US population and evaluated the status of health and nutrition of this population and their exposure to a wide range of chemicals including phthalate metabolites. CDC has reported measurable concentrations of the phthalate metabolites including mono ethyl phthalate, mono-butyl phthalate, and mono-benzyl phthalate in over 97%, and mono-2-ethyl hexyl phthalate (MEHP) and monomethyl phthalate in over 75% of the US population.
As the biomonitoring program is essential to investigate the presence of contaminants in human samples, in this research, attempts were made to investigate the concentration of three major metabolites of di-2-ethyl hexyl phthalate (DEHP) including mono (2-ethyl-5-exohexyl) phthalate, mono (2-ethyl-5-hydroxy hexyl) phthalate, and mono-(2-ethyl hexyl) phthalate in children and adolescents of Isfahan city through method development of dispersive liquid–liquid microextraction (DLLME).
| Materials and Methods|| |
The study population
A total of 242 people of children and teenagers (6–18 years of age) in Isfahan city, Iran, who were referred to developmental disorder clinics in Amin Hospital in Isfahan city were chosen randomly. Then, by getting their informed consent, their fasting urine sample was collected in a polyethylene container. Two milliliters of the urine sample was separated for determination of creatinine, and the rest of it was kept at −20°C until use.
The monoesters of MEHP, 5OH-MEHP, 5oxo-MEHP (analytical standard), β-glucuronidase enzyme (from Escherichia coli), and N-Methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA) were purchased from Sigma-Aldrich Co., whereas the other materials (methanol, HCl, acetonitrile, and chlorobenzene) were purchased from Merck Co., Germany.
Preparation of the standards
All of the utilized laboratory glasses were washed with acetone and hexane and exposed to 200°C in an oven for 24 h after being rinsed with distilled water so that the absence of phthalate compounds was ensured. Following withdrawal from oven and cooling down, the containers were rewashed with distilled water. Standard solutions of metabolites were prepared in methanol using standard experimental methods and stored in Teflon-capped amber glass bottles at −20°C until use. The concentrations of 0.001, 0.005, 0.01, 0.05, 0.1, and 0.5 μg/mL of the investigated metabolites were employed to plot calibration curve.
Preparation of the sample and extraction
The urine samples (242 persons) were kept at −20°C and before use, they were melted at room temperature. A total of 5 ml of the urine sample was poured into a glass test tube made of borosilicate, and for digesting the samples and changing the state of compounds from glucuronide state, 20 μl of the β-glucuronidase enzyme was added to it. The samples were placed inside incubator shaker device (37°C for 18 h). Once the samples were withdrawn from the incubator shaker device, 2.5 ml of the urine sample was diluted and its pH was adjusted at 2 using sulfuric acid 10% (using AD1020 pH meter). To extract the phthalate metabolites from the liquid phase, acetonitrile (as disperser) and chlorobenzene (as extractant) were used with different values. Following several times of trial and error, the best extraction was obtained at 750 μl of acetonitrile and 80 μl of chlorobenzene. Chlorobenzene and acetonitrile were injected to the samples quickly to obtain a cloudy solution. The samples were then placed in centrifuge device (for 5 min at 6000 rpm). The sediment in the bottom of the tube (20 ml) was extracted by syringe and dried by dry nitrogen gas, and following the addition of 20 μl of MSTFA for derivatization, it was injected into gas chromatography–mass spectrometry (GC/MS) device. The obtained data were analyzed by SPSS (version 16.0, IL, USA) using statistical tests. All tests were evaluated at the error value of 5%.
To measure the value of phthalate urinary metabolites, GC (Agilent, model: 7890A) equipped with MSD detector (Agilent, model: 5975C) made by Agilent Tech Co., USA, was used. Chemstation software (Win XP) was utilized to employ GC/MSD device. DB5-MS column (Agilent Co., length = 60 m, column diameter = 0.25 mm, and internal film diameter = 25 μm) was used. Helium (Grade 5.5) was used as the carrier gas with a flow rate of 1 ml/min. The injector was used at 270°C in split form with a ratio of 2:1 to inject the sample. The oven temperature began with 100°C (initial temperature), then remained at this temperature for 3 min, and after that was brought to 300°C with a rate of 20°C/min, and remained at this temperature for 7 min. The ion source temperature and transfer line temperature were adjusted at 230°C and 290°C, respectively. MSD detector was put in selected ion monitoring (SIM) mode. The ions used for SIM, retention time, and time window for the investigated metabolites are presented in [Table 1]. Calibration curves for all of the three phthalate monoesters were plotted with a coefficient of determination over 0.97 (r2 = 0.97). [Figure 2] represents a typical sample of the calibration curve for MEHP compound. To normalize the diversity of urine density, creatinine (Cr) was measured by Jaffe method using Hitachi 704 autoanalyzer.
|Table 1: Chemical structure, retention time, selected ions, and time window for investigated analytes (monoethylhexyl phthalate, MEOHP, monoethyl hydroxyl-hexyl-phthalate)|
Click here to view
|Figure 2: A calibration curve for monoethylhexyl phthalate representing all analytes|
Click here to view
To extract phthalate monoesters in biological samples (urine matrix), DLLME method was used. In DLLME, factors including the type and volume of the extractant and disperser as well as extraction time influence the extraction efficiency. To select optimal extraction conditions, a preliminary study was performed to find the suitable extractant and disperser solvent. The selected solvents were acetonitrile (disperser) and chlorobenzene (extractant). The typical chromatograms from GC/MS device for the three phthalate monoesters are shown in [Figure 3]a. In [Figure 3]b, mono ethyl phthalate of selected ions are indicated for MEHP analyte.
|Figure 3: A typical chromatogram for a standard mixture of monoethylhexyl phthalate, MEOHP, and monoethyl hydroxyl-hexyl-phthalate phthalate monoesters (a), monitored ions (m/z) of monoethylhexyl phthalate (b)|
Click here to view
The limit of detection (LOD) and limit of quantification (LOQ) were 3 and 10 times the concentration of the signal-to-noise ratio. Trueness can be assessed in large concentration ranges with recovery studies. Recovery is defined as the “proportion of the amount of analyte, present or added to the analytical portion of test material, which is extracted and presented for measurement.”
The “apparent recovery” is calculated as:
Where C is the concentration found with the method to be validated and Cref is the reference concentration.
A generally accepted definition of relative standard deviation (RSD) is “the standard deviation (S) of a set of data, divided by the mean (Xavg) of the data set, expressed in units of percent.” Thus, the formula is:
| Results|| |
The results of validation are provided in [Table 2]. The results indicate that RSD lies between 6.2% and 13.2%, suggesting the high accuracy of the experiments. The recovery of studied metabolites was obtained through calculation of the ratio of the value of a measured analyte to the real value of the metabolite. The recovery was investigated across three concentrations of low, medium, and high. Based on [Table 2], the recovery of MEHP, monoethyl oxo-hexyl-phthalate (MEOHP), and MEHHP metabolites was 55–90, 68–96, and 69%–109%, respectively. LOD and LOQ were examined for every phthalate monoester, using 3S0 and 10S0, respectively. S0 is the standard deviation obtained from the blank analysis (in this study: 15 blank analyses). LOD and LOQ are presented in [Table 2] for each studied monoester. LOD and LOQ for the studied monoesters were around 0.02–0.09 and 0.05–0.5 μg/L, respectively. Based on [Table 3] and comparison with other studies, the results show that the detection limit, detection value, RSD, and recovery of the utilized method are desirable.
|Table 2: The results of validation of dispersive liquid-liquid microextraction/gas chromatography-mass spectrometry method for monoester phthalate analytes|
Click here to view
|Table 3: Mean concentration, creatinine-adjusted concentration, and median of mono ethylhexyl-phthalate, MEOHP, and monoethyl hydroxyl-hexyl-phthalate analytes in investigated population|
Click here to view
Monitoring the phthalate monoesters in the studied population
From the 242 people under investigation, 140 (57.9%) and 102 (42.1%) participants were female and male, respectively. MEHP, MEOHP, and MEHHP were observed in 99.6%, 95.87%, and 96.28% of the studied samples, respectively. According to [Table 3], the mean concentration of MEOHP is greater than that of MEHHP and MEHP. Furthermore, in this table, the mean concentration adjusted with creatinine has also been provided.
| Discussion|| |
LOD and LOQ are presented in [Table 2] for each studied monoester. LOD and LOQ for the studied monoesters were around 0.02–0.09 and 0.05–0.5 μg/L, respectively. Based on [Table 4] and comparison with other studies, the results show that the LOD, limit of quantification, RSD, and recovery of the utilized method are desirable.
|Table 4: Comparison of the current study with other studies about biomonitoring phthalate metabolites|
Click here to view
According to [Table 4], and based on a study of Herrero et al., determination of primary and secondary phthalate metabolites in urine samples was conducted by GC/MS. Extraction was done by hexane (2 mL) and sodium chloride (0.3 g). For derivatization, dichloromethane (80 mL), (TMSDM )trimethylsilyldiazomethane (1.5 mL), and methanol (15 mL) were added. Comparison of the current study showed that LOD and LOQ in this study were lower than this shows the higher accuracy of method development by acetonitrile and chlorobenzene. On the other hand, RSD in this study (6.2–13.2) was higher than the study of Herrero et al. Based on [Table 3], the highest analyte concentration in the studied population is related to MEOHP. The concentration median and median adjusted concentration for MEOHP were 257.9 ± 143.4 and 845.6 ± 559.8 μg/L, respectively. On the other hand, the geometric mean of MEHP, MEOHP, and MEHHP in the male gender was 83.7, 191.9, and 132.2 μg/L, respectively. The geometric mean of these compounds in the female gender was 75, 169.6, and 102.6 μg/L, respectively. According to independent t-test analysis, no significant difference was observed between the male and female groups in terms of the level of studied metabolites (P value [MEHP] = 0.55,9 P value [MEOHP] = 0.269, andP value [MEHHP] = 0.231). These results have a significant difference with the investigations by NHANES in 2012. According to the investigation by this institute, the geometric mean of MEHP, MEOHP, and MEHHP in the male gender was 1.51, 5.5, and 8.71 μg/L, respectively, whereas in the female gender, the values were 1.24, 4.71, and 7.2 μg/L, respectively. In spite of the limited number of samples in this study, the obtained results indicate a significant difference with the uses of phthalate diesters in Iran (Isfahan) and the USA. According to NHANES investigation, from 1999 to 2012, the level of DEHP metabolites has had a significant decrease in the studied groups, which can be due to the strict rules that have been enforced in some countries including American and European countries. DEHP is one of the most widely used phthalate esters, especially in the packaging industry. As chemically DEHP does not attach to the polymer, and during the production and application, it is easily detached off the polymer; thus, it can transfer through in air, water, food, and medical equipment (e.g., blood bags and injection instruments). However, the most important source of exposure to phthalate compounds for a human is through swallowing. According to the investigations in this study, questions were asked about usage of plastic packaging for storage of foods and usage of plastic toys by children, where 64.9% of the households used plastic packaging. Nearly 71.5% of the children used plastic toys, which can be the main reason for the higher level of DEHP metabolites in the urine of the studied group. In the study by Song et al. on biomonitoring of DEHP metabolites, the results indicated that the geometric mean of MEHP, MEOHP, and MEHHP metabolites in South Korean children was 18.7, 111.1, and 109.1 μ/g of creatinine, which are lower values than those obtained in this study. The geometric mean of MEOHP and MEHHP in the study of Meeker et al. on male population of Boston city in Massachusetts state was 36.2 and 55.6 μg/L, respectively, with these values in this study around five and two times as large as Meeker's study, respectively.
In the study conducted by Kim et al. in Korea, the mean concentration of MEHP, MEOHP, and MEHHP metabolites was 14.4, 34.77, and 26.75 μg/g of creatinine, respectively. The results of the present study indicate that the concentration of these metabolites in Isfahan (Iran) is 25.9, 22.6, and 20 times more than their concentration in Korea. The concentrations of the three DEHP metabolites in this study were significantly correlated with each other according to Pearson correlation (P < 0.001), suggesting that these metabolites originate from a single mother compound (DEHP).
| Conclusion|| |
In this study, DLLME method was employed for extracting diethyl hexyl phthalate monoesters in urine matrix. Validation of the data indicates that the studied method is reliable (RSD = 6.2%–13.2%). On the other hand, LOD = 0.024–0.088 and LOQ = 0.05–0.48 in this method in comparison with other methods reveal the accuracy of the studied method. The mean concentration of MEHP, MEOHP, and MEHHP monoesters in the studied population was 151.7 ± 143.8, 258.143 ± 26.07, and 194.17 ± 147.3 μg/L, respectively, which are very high values in comparison with other similar studies that requires the attention and legislation regarding limitation of the application of phthalate compounds. It also highlights the necessity of biomonitoring in human samples more than ever.
The authors wish to thank Vice Chancellor for Research of Isfahan University of Medical Sciences, Iran, for the financial support.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Zarean M, Bina B, Ebrahimi A, Pourzamani HR, Esteki F. Degradation of di-2-ethylhexyl phthalate in aqueous solution by advanced oxidation process. Int J Environ Health Eng 2015;4:1-7.
Julinová M, Slavík R. Removal of phthalates from aqueous solution by different adsorbents: A short review. J Environ Manage 2012;94:13-24.
Erythropel HC, Maric M, Cooper DG. Designing green plasticizers: Influence of molecular geometry on biodegradation and plasticization properties. Chemosphere 2012;86:759-66.
Lessmann F, Schütze A, Weiss T, Brüning T, Koch HM. Determination of metabolites of di(2-ethylhexyl) terephthalate (DEHTP) in human urine by HPLC-MS/MS with on-line clean-up. J Chromatogr B Analyt Technol Biomed Life Sci 2016;1011:196-203.
Kastner J, Cooper DG, Marić M, Dodd P, Yargeau V. Aqueous leaching of di-2-ethylhexyl phthalate and “green” plasticizers from poly (vinyl chloride). Sci Total Environ 2012;432:357-64.
Svensson K, Hernández-Ramírez RU, Burguete-García A, Cebrián ME, Calafat AM, Needham LL, et al.
Phthalate exposure associated with self-reported diabetes among Mexican women. Environ Res 2011;111:792-6.
Trasande L, Sathyanarayana S, Jo Messito M, S Gross R, Attina TM, Mendelsohn AL, et al.
Phthalates and the diets of U.S. Children and adolescents. Environ Res 2013;126:84-90.
Gao CJ, Liu LY, Ma WL, Ren NQ, Guo Y, Zhu NZ, et al.
Phthalate metabolites in urine of Chinese young adults: Concentration, profile, exposure and cumulative risk assessment. Sci Total Environ 2016;543:19-27.
Téllez-Rojo MM, Cantoral A, Cantonwine DE, Schnaas L, Peterson K, Hu H, et al.
Prenatal urinary phthalate metabolites levels and neurodevelopment in children at two and three years of age. Sci Total Environ 2013;461-462:386-90.
Park C, Choi W, Hwang M, Lee Y, Kim S, Yu S, et al.
Associations between urinary phthalate metabolites and bisphenol A levels, and serum thyroid hormones among the Korean adult population – Korean National Environmental Health Survey (KoNEHS) 2012-2014. Sci Total Environ 2017;584-585:950-7.
Boas M, Feldt-Rasmussen U, Skakkebaek NE, Main KM. Environmental chemicals and thyroid function. Eur J Endocrinol 2006;154:599-611.
Becker K, Göen T, Seiwert M, Conrad A, Pick-Fuss H, Müller J, et al.
GerES IV: Phthalate metabolites and bisphenol A in urine of German children. Int J Hyg Environ Health 2009;212:685-92.
Hines EP, Calafat AM, Silva MJ, Mendola P, Fenton SE. Concentrations of phthalate metabolites in milk, urine, saliva, and serum of lactating North Carolina women. Environ Health Perspect 2009;117:86-92.
Ye X, Pierik FH, Hauser R, Duty S, Angerer J, Park MM, et al.
Urinary metabolite concentrations of organophosphorous pesticides, bisphenol A, and phthalates among pregnant women in Rotterdam, the Netherlands: The generation R study. Environ Res 2008;108:260-7.
Frederiksen H, Nielsen JK, Mørck TA, Hansen PW, Jensen JF, Nielsen O, et al.
Urinary excretion of phthalate metabolites, phenols and parabens in rural and urban Danish mother-child pairs. Int J Hyg Environ Health 2013;216:772-83.
Saravanabhavan G, Guay M, Langlois É, Giroux S, Murray J, Haines D, et al.
Biomonitoring of phthalate metabolites in the Canadian population through the Canadian Health Measures Survey (2007-2009). Int J Hyg Environ Health 2013;216:652-61.
Lewis RC, Meeker JD, Peterson KE, Lee JM, Pace GG, Cantoral A, et al.
Predictors of urinary bisphenol A and phthalate metabolite concentrations in Mexican children. Chemosphere 2013;93:2390-8.
CDC. U. Fourth National Report on Human Exposure to Environmental Chemicals, National Center for Environmental Health. Atlanta, GA: Centers for Disease Control and Prevention; 2015.
Chen M, Tao L, Collins EM, Austin C, Lu C. Simultaneous determination of multiple phthalate metabolites and bisphenol-A in human urine by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2012;904:73-80.
Khalil N, Chen A, Lee M. Endocrine disruptive compounds and cardio-metabolic risk factors in children. Curr Opin Pharmacol 2014;19:120-4.
Kim M, Song NR, Choi JH, Lee J, Pyo H. Simultaneous analysis of urinary phthalate metabolites of residents in Korea using isotope dilution gas chromatography-mass spectrometry. Sci Total Environ 2014;470-471:1408-13.
Dirven HA, van den Broek PH, Jongeneelen FJ. Determination of four metabolites of the plasticizer di(2-ethylhexyl) phthalate in human urine samples. Int Arch Occup Environ Health 1993;64:555-60.
Kondo F, Ikai Y, Hayashi R, Okumura M, Takatori S, Nakazawa H, et al.
Determination of five phthalate monoesters in human urine using gas chromatography-mass spectrometry. Bull Environ Contam Toxicol 2010;85:92-6.
Song NR, On JW, Lee J, Park JD, Kwon HJ, Yoon HJ, et al.
Biomonitoring of urinary di(2-ethylhexyl) phthalate metabolites of mother and child pairs in South Korea. Environ Int 2013;54:65-73.
Herrero L, Calvarro S, Fernández MA, Quintanilla-López JE, González MJ, Gómara B, et al.
Feasibility of ultra-high performance liquid and gas chromatography coupled to mass spectrometry for accurate determination of primary and secondary phthalate metabolites in urine samples. Anal Chim Acta 2015;853:625-36.
Ait Bamai Y, Araki A, Kawai T, Tsuboi T, Yoshioka E, Kanazawa A, et al.
Comparisons of urinary phthalate metabolites and daily phthalate intakes among japanese families. Int J Hyg Environ Health 2015;218:461-70.
Myridakis A, Balaska E, Gkaitatzi C, Kouvarakis A, Stephanou EG. Determination and separation of bisphenol A, phthalate metabolites and structural isomers of parabens in human urine with conventional high-pressure liquid chromatography combined with electrospray ionisation tandem mass spectrometry. Anal Bioanal Chem 2015;407:2509-18.
Blount BC, Milgram KE, Silva MJ, Malek NA, Reidy JA, Needham LL, et al.
Quantitative detection of eight phthalate metabolites in human urine using HPLC-APCI-MS/MS. Anal Chem 2000;72:4127-34.
Meeker JD, Calafat AM, Hauser R. Urinary metabolites of di(2-ethylhexyl) phthalate are associated with decreased steroid hormone levels in adult men. J Androl 2009;30:287-97.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3], [Table 4]